---
layout: default
contributors: FDA Center for Drug Evaluation and Research
description: The publication Approved Drug Products with Therapeutic Equivalence Evaluations
  (commonly known as the Orange Book) identifies drug products approved on the basis
  of safety and effectiveness by the Food and Drug Administration (FDA) under the
  Federal Food, Drug, and Cosmetic Act (the Act) and related patent and exclusivity
  information.
last_edit: Mon, 19 Jun 2023 16:35:46 GMT
location: https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book
maintained_by: 'The Orange Book downloadable data files are updated monthly. We make
  every effort to prevent errors and discrepancies in the Approved Drug Products data
  files; however, if you wish to report an error or discrepancy in drug data, please
  send a brief description of the problem to orangebook@fda.hhs.gov.


  General questions related to the drug data in these files should be directed to
  the Center for Drug Evaluation and Research, Division of Drug Information druginfo@fda.hhs.gov.'
open_access: 'FALSE'
related_projects:
  parent:
  - orangebook_nber
shortname: orangebook_fda
tags:
- drugs
- pharmaceuticals
- us
- exclusivity
title: FDA Orange Book Database
uuid: dc9b201c-5f40-4aca-9f40-b7e1dcee5c67
versioning: 'FALSE'
---